Youssef MA

No ORCID on file · 12 papers in corpus · active 2014-2020

Study types

  • other 1
  • rct 1

Condition tags

  • infertility 5
  • endometriosis 2
2020
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa241

Study questionCan a core outcome set to standardize outcome selection, collection and reporting across future infertility research be developed?Summary answerA minimum data set, known as a core outcome set, has been developed for randomized…

2020
Journal of ovarian research ·doi:10.1186/s13048-020-00665-0

BackgroundThe aim of this study was to determine whether the treatment with doxycycline before and after oocyte retrieval is as effective as salpingectomy in minimizing the detrimental effect of hydrosalpinx on the outcomes of IVF-ET.Method…

2020
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaa243

Study questionCan consensus definitions for the core outcome set for infertility be identified in order to recommend a standardized approach to reporting?Summary answerConsensus definitions for individual core outcomes, contextual statement…

other 2020
Human Reproduction ·doi:10.1093/humrep/deaa242

STUDY QUESTION: Can the priorities for future research in infertility be identified? SUMMARY ANSWER: The top 10 research priorities for the four areas of male infertility, female and unexplained infertility, medically assisted reproduction…

2018
Human reproduction open ·doi:10.1093/hropen/hoy007

Study questionsWe aim to produce, disseminate and implement a core outcome set for future infertility research.What is known alreadyRandomized controlled trials (RCTs) evaluating infertility treatments have reported many different outcomes,…

2016
Journal of ovarian research ·doi:10.1186/s13048-016-0237-8

BackgroundThe aim of this study was to compare the efficacy of antagonist rescue protocol (replacing GnRH agonist with GnRH antagonist and reducing the dose of gonadotropins) combined with cabergoline versus cabergoline alone in the prevent…

2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd001750.pub4

BackgroundGonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regulati…

2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd003719.pub4

BackgroundFor the last few decades urinary human chorionic gonadotrophin (uhCG) has been used to trigger final oocyte maturation in cycles of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Recombinant technology h…

2015
Journal of Advanced Research ·doi:10.1016/j.jare.2015.01.005

Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a GnRH agonist. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of the…

2015
BMC women's health ·doi:10.1186/s12905-015-0228-8

BackgroundTo our knowledge, no large population - based studies have been performed on the topic of menstrual patterns among Egyptian adolescent in recent years. The aims of this study were to identify menstrual patterns and associated diso…

rct 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.02.001

OBJECTIVE: Follicular fluid of mature oocytes is rich in growth factors and cytokines that may exert paracrine and autocrine effects on implantation. The aim of this study was to investigate if flushing the endometrial cavity with follicula…

2014
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd008046.pub4

BackgroundHuman chorionic gonadotropin (HCG) is routinely used for final oocyte maturation triggering in in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) cycles, but the use of HCG for this purpose may have drawbacks. Go…